Case Report: Use of endobronchial Watanabe spigot and coagulation factor XIII supplementation in the treatment of persistent pneumothorax due to pneumocystis pneumonia with human immunodeficiency virus infection

Katsumasa Koyama; Daisuke Minami; Hayato Isobe; Ryo Shirai; Niro Okimoto; Koichi Tomoda

doi:10.3389/fmed.2022.956333

Frontiers in Medicine (Oct 2022)

Case Report: Use of endobronchial Watanabe spigot and coagulation factor XIII supplementation in the treatment of persistent pneumothorax due to pneumocystis pneumonia with human immunodeficiency virus infection

Katsumasa Koyama,
Daisuke Minami,
Hayato Isobe,
Ryo Shirai,
Niro Okimoto,
Koichi Tomoda

Affiliations

Katsumasa Koyama: Department of General Internal Medicine 1, Kawasaki Medical School, Okayama, Japan
Daisuke Minami: Department of Respiratory Medicine, Hosoya Hospital, Okayama, Japan
Hayato Isobe: Department of General Internal Medicine 1, Kawasaki Medical School, Okayama, Japan
Ryo Shirai: Department of General Internal Medicine 1, Kawasaki Medical School, Okayama, Japan
Niro Okimoto: Department of General Internal Medicine 1, Kawasaki Medical School, Okayama, Japan
Koichi Tomoda: Department of General Internal Medicine 1, Kawasaki Medical School, Okayama, Japan

DOI: https://doi.org/10.3389/fmed.2022.956333
Journal volume & issue: Vol. 9

Abstract

Read online

Pneumocystis jiroveceii pneumonia is one of the most common opportunistic infections associated with human immunodeficiency virus. Endobronchial Watanabe spigot has been recommended for refractory pneumothorax, even with persistant air leak despite continuous negative pressure control via thoracic drainage. Moreover, coagulation factor XIII is considered effective in wound healing.

Published in Frontiers in Medicine

ISSN: 2296-858X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Medicine (General)
Website: http://www.frontiersin.org/journals/medicine

About the journal

Abstract

Keywords